Table I.
TXNIP expression | |||
---|---|---|---|
Clinicopathological features | Patient number | High, n (%) | Low, n (%) |
WHO grade | |||
I | 7 | 6 (86) | 1 (14) |
II | 22 | 18 (82) | 4 (18) |
III | 20 | 4 (20) | 16 (80) |
IV | 5 | 0 (0) | 5 (100) |
Age, years | |||
<55 | 42 | 23 (55) | 19 (45) |
≥55 | 12 | 5 (42) | 7 (58) |
Sex | |||
Male | 24 | 10 (42) | 14 (58) |
Female | 30 | 18 (60) | 12 (40) |
TXNIP, thioredoxin-interacting protein; WHO, World Health Organization.